Purchase Order 36C26126P0068
Award Date 10/14/25
Potential Completion Date 12/14/25
Potential Value $30K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Cary, NC 27513, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $21,535.58 firm fixed-price purchase order awarded by the Federal Medical Center Carswell, a civilian agency, to Biologics, Inc., a for-profit pharmaceutical provider. The order is for cancer drug biologics to be delivered by November 30, 2024. Biologics, Inc. is a subsidiary of the larger McKesson Corporation, which is a major healthcare services and IT company that has provided over $5.8 million in pharmaceutical products to the Department of Veterans Affairs and Indian Health...
- This is a firm fixed-price purchase order contract awarded by the Federal Medical Center Carswell, a civilian agency, to Biologics, Inc., a subsidiary of the healthcare company McKesson Corporation. The $22,061.05 contract is for the delivery of cancer drugs and biologics, including medications such as TURALIO, CAPRELSA, LENALIDOMIDE, AYVAKIT, and XERMELO. The contract does not have a set-aside designation, indicating it was open to full and open competition. Biologics, Inc. has a history of...
- This is a firm fixed-price purchase order for $91,279.43 awarded by the Veterans Integrated Service Network 22, a component of the Department of Veterans Affairs (VA), to Biologics, Inc. to provide the cancer medication Lynparza on an emergency basis. The contract period was from November 6, 2015 to September 30, 2016. This contract was not set aside for any specific business category. Biologics, Inc. is a for-profit pharmaceutical company that has provided specialty medications to various...
- This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 19 (VISN 19), a civilian agency under the Department of Veterans Affairs (VA), to Mckesson Plasma And Biologics LLC, a for-profit limited liability company, for pharmaceutical products and medical supplies. The contract has a total ceiling value of $103,728.96 and a completion date of June 30, 2015. The contract does not have a set-aside designation. Mckesson Plasma And Biologics LLC, a subsidiary of...
- This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 1 (VISN 1), a division of the Department of Veterans Affairs (VA), to Mckesson Plasma And Biologics LLC, a for-profit limited liability company. The contract, valued at $145,440.00, is for the provision of pharmaceutical medications to support direct patient care for specific patients. The contract has an ultimate completion date of February 25, 2016. Mckesson Plasma And Biologics LLC, a subsidiary of...
- This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 19 to Biologics, Inc., a for-profit pharmaceutical provider, for $99,184.84. The contract is for express pharmacy orders, with a period of performance ending on September 30, 2017. Biologics, Inc. has provided specialty medications such as cancer treatments to VA medical centers and Bureau of Prisons facilities in the past. This award does not have a set-aside...
- This is a delivery order contract awarded by the Veterans Integrated Service Network 21 (VISN 21), a civilian agency, to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The contract is for the supply of the drug LENALIDOMIDE, with a firm fixed price and a ceiling value of $10,397.52. The contract has an ultimate completion date of October 17, 2025. Exelan Pharmaceuticals is a key supplier of pharmaceutical products to various...
- This is a firm fixed price purchase order contract awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 20 to McKessson Corporation, a healthcare services and information technology company. The contract is for the delivery of Melphalan Hydrochloride 50mg vials, a pharmaceutical product. The contract has a ceiling value of $101,056.68 and an ultimate completion date of March 22, 2017. The contract was not set aside for any specific business type. McKessson...
- This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs to McKesson Corporation, a prime contractor, for the delivery of MELPHALAN INJ 50 MG VIALS. The contract has a ceiling value of $89,828.16 and a period of performance ending on December 14, 2016. No set-aside designation was used. Based on the information provided, McKesson Corporation, also known as McKesson Drug Company, is a healthcare services and information technology company that provides...
- The U.S. Department of Veterans Affairs (VA) awarded a firm fixed-price purchase order to Mckesson Plasma And Biologics LLC, a subsidiary of Mckesson Corporation, for the delivery of belzutifan 40mg capsules. The contract, valued at $22,051.39, has an ultimate completion date of April 30, 2025. The award was made through the Veterans Integrated Service Network 2 (VISN 2), a regional network within the VA's healthcare system. The contract does not have a set-aside designation. Mckesson Plasma And...